CF
BMY icon

Corebridge Financial’s Bristol-Myers Squibb BMY Stock Holding History

Corebridge Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-452,608
Closed -$27.6M – 393
2025
Q1 		$27.6M Sell
452,608
-13,531
-3% -$789K 0.16% 99
2024
Q4 		$26.4M Sell
466,139
-22,144
-5% -$1.24M 0.14% 102
2024
Q3 		$25.3M Sell
488,283
-14,074
-3% -$660K 0.13% 109
2024
Q2 		$20.9M Buy
+502,357
New +$22.5M 0.11% 127

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Corebridge Financial's BMY Position: Q2 2025 in Review

Corebridge Financial sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 452,608 shares — an estimated $27.6M sold.

Corebridge Financial first reported a position in BMY in Q2 2024 and held it in 4 quarters. The position peaked at $27.6M in Q1 2025. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Corebridge Financial reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 452,608 Bristol-Myers Squibb shares in Q2 2025, an estimated $27.6M.
  • Corebridge Financial first reported a position in Bristol-Myers Squibb in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Bristol-Myers Squibb position peaked at $27.6M in Q1 2025.
  • 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.